KBC Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,038
Closed -$418K 1577
2022
Q3
$418K Hold
20,038
﹤0.01% 792
2022
Q2
$416K Buy
20,038
+9,043
+82% +$161K ﹤0.01% 799
2022
Q1
$185K Hold
10,995
﹤0.01% 1062
2021
Q4
$220K Hold
10,995
﹤0.01% 1058
2021
Q3
$199K Sell
10,995
-97,431
-90% -$2.23M ﹤0.01% 1073
2021
Q2
$2.93M Sell
108,426
-3,104
-3% -$86.8K 0.01% 720
2021
Q1
$3.34M Buy
111,530
+85,380
+327% +$2.91M 0.01% 679
2020
Q4
$4.13M Sell
26,150
-2,060
-7% -$55.6K ﹤0.01% 887
2020
Q3
$688K Sell
28,210
-4,378
-13% -$94.4K ﹤0.01% 862
2020
Q2
$582K Buy
32,588
+5,262
+19% +$69.2K ﹤0.01% 939
2020
Q1
$222K Buy
27,326
+2,426
+10% +$27.7K ﹤0.01% 1005
2019
Q4
$329K Sell
24,900
-6,808
-21% -$82.4K ﹤0.01% 1206
2019
Q3
$377K Buy
31,708
+12,719
+67% +$235K ﹤0.01% 1148
2019
Q2
$465K Buy
18,989
+4,880
+35% +$141K ﹤0.01% 1083
2019
Q1
$449K Buy
+14,109
New +$501K ﹤0.01% 1110

Other funds holding CVET

KBC Group's CVET Position: Q4 2022 in Review

KBC Group sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 20,038 shares — an estimated $418K sold.

KBC Group first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $4.13M in Q4 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • KBC Group reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • KBC Group sold 20,038 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $418K.
  • KBC Group first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • KBC Group's Covetrus, Inc. Common Stock position peaked at $4.13M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on KBC Group's 13F filing for Q4 2022, filed 13 Feb 2023.